PSYBIO THERAPEUTICS
PsyBio Therapeutics is an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health challenges and other disorders. The team has extensive experience in drug discovery based on synthetic biology and metabolic engineering as well as clinical and regulatory expertise progressing drugs through human studies and regulatory protocols. Research and development is currently on... going for naturally occurring psychoactive tryptamines originally discovered in different varieties of hallucinogenic mushrooms, other tryptamines and phenethylamines and combinations thereof. The Company is also researching and developing new non-naturally occurring molecular structures which may have unique therapeutics properties.
PSYBIO THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care
Founded:
2009-01-01
Address:
Coconut Creek, Florida, United States
Country:
United States
Website Url:
http://www.psybiolife.com
Total Employee:
11+
Status:
Active
Contact:
513-449-9585
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro IPv6 Google Apps For Business Cloudflare GStatic Google Static Content
Similar Organizations
Alethia BioTherapeutics
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
ProChon Biotech
ProChon is a biotechnology company developing a fibroblast growth factor system for tissue regeneration.
Current Employees Featured
Founder
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2021-04-05 | PsyBio Strengthens its Leadership Team with Appointment of Dr. Michael Spigarelli as Chief Medical Officer |
Official Site Inspections
http://www.psybiolife.com Semrush global rank: 4.67 M Semrush visits lastest month: 2.1 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "PsyBio Therapeutics"
PsyBio Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 513-449-9585 PsyBio Therapeutics is an intellectual property driven biotechnology company developing novel formulations of …See details»
PsyBio Therapeutics Company Description - Stock Analysis
Nov 15, 2024 PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the …See details»
PsyBio Therapeutics Initiates Pilot Scale Development of
Mar 2, 2021 PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research, Development and Manufacturing Organization …See details»
PsyBio Therapeutics Announces Pre-IND Application Request
Sep 23, 2021 www.psybiolife.com. × Modal title. Organization Profile. PsyBio Therapeutics Corp. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact Us Become a Client; Request a …See details»
PsyBio Therapeutics Announces TSXV Approval of Share Buyback …
Jun 28, 2021 www.psybiolife.com. × Modal title. Organization Profile. PsyBio Therapeutics Corp. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact Us Become a Client; Request a …See details»
PsyBio Therapeutics Corp | LinkedIn
PsyBio Therapeutics Corp | 2,774 followers on LinkedIn. Pioneering The Next Generation Of Targeted Psychoactive Medications | PsyBio Therapeutics is developing biosynthetic …See details»
PsyBio and Miami University Broaden Partnership Agreement
Apr 26, 2021 https://www.psybiolife.com. × Modal title. Organization Profile. PsyBio Therapeutics Inc. Related Organization(s) Miami University. Contact Cision. 866-245-2317 …See details»
PsyBio Therapeutics - Craft
Apr 5, 2024 Net income (Q2, 2023)($145.0K) Cash (Q2, 2023)$12.0K EBIT (Q2, 2023)($92.0K) Enterprise value $1.3MSee details»
PsyBio Therapeutics Initiates Pilot Scale Development of …
Mar 2, 2021 OXFORD, Ohio and COCONUT CREEK, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a …See details»
PsyBio Therapeutics Announces Retention of Market Maker
Mar 4, 2021 Generation is a member of the Investment Industry Regulation Organization of Canada (IIROC) and a member firm of the TSXV. ... [email protected]. Media Enquiries: …See details»
PsyBio Therapeutics Initiates Pilot Scale Development of
Mar 2, 2021 OXFORD, Ohio and COCONUT CREEK, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a …See details»
Miami University Researchers Collaborate with PsyBio
May 22, 2020 Contact Information: Evan Levine, CEO 5134499585 [email protected] www.psybiolife.com Wire Service Contact NetworkWire (NW) New York, New York …See details»
PsyBio Therapeutics Increases Intellectual Property Portfolio with ...
May 12, 2021 Patent portfolio now includes four pending provisionals and one pending non-provisional patent application. OXFORD, Ohio and COCONUT CREEK, Fla., May 12, 2021 …See details»
PsyBio Therapeutics Corp. (PSYBF) - Yahoo Finance Canada
Find the latest PsyBio Therapeutics Corp. (PSYBF) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
PsyBio Therapeutics Furthers Intellectual Property Portfolio with …
Nov 19, 2021 www.psybiolife.com. × Modal title. Organization Profile. PsyBio Therapeutics Corp. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact Us Become a Client; Request a …See details»
PsyBio Therapeutics Awarded Approval to Manufacture …
Jul 21, 2023 "PsyBio has worked diligently to achieve formal written approval to allow full scale manufacturing of its proprietary biosynthetic tryptamines, including our lead compound PsyBio …See details»
PsyBio Therapeutics Initiates Pilot Scale Development of …
Mar 2, 2021 Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.See details»
PsyBio Therapeutics Initiates Pilot Scale Development of …
Mar 2, 2021 OXFORD, Ohio and COCONUT CREEK, Fla., March 02, 2021 (GLOBE NEWSWIRE) — PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a …See details»
PsyBio Therapeutics Initiates Pilot Scale Development of …
Evan Levine CEO, PsyBio Therapeutics Corp. t: 226.286.0348 e: [email protected]. Media Enquiries: Kirsten Frazer, PhD LifeSci Communications t: 646.863.0222 e: …See details»
PsyBio Therapeutics Successfully Demonstrates Commercial Scale ...
Oct 7, 2021 www.psybiolife.com. × Modal title. Organization Profile. PsyBio Therapeutics Corp. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact Us Become a Client; Request a …See details»